Related Experiment Video
Updated: Jun 28, 2026

07:17
Wild-type Blocking PCR Combined with Sanger Sequencing for Detection of Low-frequency Somatic Mutation
Published on: August 23, 2024
Peri-transplant TP53 molecular MRD as a prognostic biomarker of relapse in TP53-mutated AML/MDS undergoing allogeneic
Yeqian Zhao1,2,3, Weijie Cao4, Jimin Shi1,2,3
1Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, HangZhou, 311100, China.
Blood Cancer Journal
|June 26, 2026
Abstract
No abstract available in PubMed .
